Developing and commercializing a new life sciences product or service requires meticulous research, planning, strategy and management. It often encompasses different goals than research and grant funding. There are several necessary steps, and a strategy needs to be well defined in order to be successful.
Product development requires input from and between various groups within a company and, for academia, outside entities. The product development stakeholder groups/entities are research, marketing, development, regulatory, manufacturing, clinical, safety/efficacy, and quality. Companies use different strategies for efficient product development such as outsourcing all development activities or jointly using public-private partnerships. During this expert class experienced entrepreneurs will talk about their strategies and lessons learned for the efficient development of (bio)pharmaceutical products and diagnostic services.
The expert class program is set up in an interactive way such that the participants have also the possibility to bring their own questions and discuss issues they encounter in their own (start-up) company and/or business case. The expert class will also give the possibility to broaden the participants network.
Date and Time: 22 October 2021, 13.00 – 18.00 hrs. CET
Venue: BTF - Biotech Training Facility, Leiden Bio Science Park
|
13.00 hrs. |
Start registration |
|
13.30 hrs. |
Welcome by Chrétien Herben (moderator) |
|
|
Pitch participants (2 min. per participant):
|
|
14.00 hrs. |
Dr. Jan Groen, CEO Intravacc |
|
|
Intravacc is one of the world’s leading institutes for translational vaccinology. As an established independent R&D organization with over 100 years’ experience in the development and optimization of vaccines and vaccine technologies, Intravacc has transferred its technology all over the globe, including oral polio vaccines, measles vaccines, and DPT, Hib and influenza vaccines. Jan Groen will address product development from a diagnostic product and vaccine perspective. Besides a good team, efficient organisation and good science much more is needed to get a drug, diagnostic test or medical device to the market. A good strategy how to communicate and build relations with external stakeholders like investors, health care insurance organisations (reimbursement) and key opinion leaders is crucial to get your product to the patients. How do you communicate and build relations with external stakeholders like health care insurance companies, key opinion leaders and financing Investors? |
|
15:00 hrs. |
Gert Scheper, Compound Development Team Leader (CDTL), COVID-19 Vaccine at The Janssen Pharmaceutical Companies of Johnson & Johnson |
|
|
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Gert Scheper will talk about how product development within Janssen is organised. Which internal stakeholder groups are involved in the product development process and decision making? |
|
15:45 hrs. |
Dave Seghers, Business Development Director at Ardena |
|
|
Ardena is a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug substance and products for clinical trials. Outsourcing strategy is especially for young companies often the only option for early stage drug development. How does it work and what are terms for collaboration with a contract development organisation? In addition what are the pro’s and con’s and the lessons learned from a CDMO perspective when working together with young companies. |
|
16:30 hrs. |
Discuss questions and issues from participants with the experts |
|
16.45 hrs. |
Drinks, bites and networking! |
|
18.00 hrs. |
End of Expert Class |
LifeSciences@Work Expert Classes are a series of targeted (virtual) workshops organized in close collaboration with industry and academic experts
- The small-scale and personalized Expert Classes welcome Venture Challenge Alumni, Value Centre Alumni and NWO Take off Alumni.
- New early startups not (yet) part of our LS@W community but interested to join are also very welcome, provided there is a match with the LS@W community profile.
- Participation is free-of-charge for startup teams.